Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for nightmares in posttraumatic stress disorder
2019-002211-25Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in post-traumatic stress disorder (PTSD) comparing Dronabinol with Placebo (2 arms). Primary endpoint: Frequency and intensity of nightmares at end of treatment. Started Oct 2019; status: completed.
02
Drugs
dronabinol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2019-002211-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002211-25.